Protein deamidation in biopharmaceutical manufacture: understanding, control and impact

What is it about?

Pharmaceutical products can degrade, making them potentially less useful. Manufacturers need to monitor these types of degradation. This paper provides a short review of how researchers and manufacturers are addressing one type of degradation, called deamidation.

Featured Image

Why is it important?

More diverse strategies than ever are being employed in control of deamidation during biopharmaceutical manufacture. This paper provides a summary of these strategies, which may be useful to those in process development.